apomorphine has been researched along with rotenone in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Wesemann, W | 1 |
| Banerjee, R; Mohanakumar, KP; Raju, BC; Rao, JM; Saravanan, KS; Senthilkumar, KS; Sindhu, KM | 1 |
| Cao, X; Chen, C; Huang, J; Jia, M; Liang, Z; Lin, Z; Sun, S; Wang, T; Xiong, J; Xiong, N; Zhang, Z | 1 |
| Colwell, KL; Gidyk, DC; Klein, A; Metz, GA; Shriner, AM; Tatton, NA; Tatton, WG | 1 |
| Erbaş, O; Oltulu, F; Taşkiran, D | 1 |
| Karuppagounder, SS; Madathil, SK; Mohanakumar, KP | 1 |
| Chen, NH; Chu, SF; Li, J; Liu, Y; Song, LK; Sun, JD; Yuan, YH | 1 |
| Chen, NH; Shao, SY; Song, XY; Xia, CY; Yang, YN; Zhang, PC; Zhang, S | 1 |
| Avcı, B; Balcı, H; Bilge, SS; Bozkurt, A; Günaydın, C; Önger, ME | 1 |
| Bilal, B; Erbas, O; Erdogan, MA; Kirazlar, M; Yigitturk, G | 1 |
12 other study(ies) available for apomorphine and rotenone
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Therapy of Morbus Parkinson and radical-induced neurotoxicity in the rat--in vivo voltammetric studies.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Antiparkinson Agents; Apomorphine; Corpus Striatum; Dopamine; Electrochemistry; Free Radicals; Haloperidol; Hydroxyindoleacetic Acid; Male; Memantine; Neurotoxins; Parkinson Disease; Rats; Rats, Wistar; Rotenone; Serotonin; Substantia Nigra | 1992 |
Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Apomorphine; Behavior, Animal; Corpus Striatum; Dextroamphetamine; Dopamine; Male; Medial Forebrain Bundle; Oxidopamine; Rats; Rotation; Rotenone; Substantia Nigra | 2006 |
Long-term efficacy and safety of human umbilical cord mesenchymal stromal cells in rotenone-induced hemiparkinsonian rats.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apomorphine; Brain; Carbocyanines; Cell Differentiation; Cell Movement; Corpus Striatum; Dose-Response Relationship, Drug; Epilepsy; Female; Humans; Intermediate Filament Proteins; Locomotion; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Neoplasm Proteins; Nerve Tissue Proteins; Nestin; Neurons; Parkinsonian Disorders; Pentylenetetrazole; Phosphopyruvate Hydratase; Rats; Rats, Sprague-Dawley; Rotation; Rotenone; Staining and Labeling; Substantia Nigra; Treatment Outcome; Tyrosine 3-Monooxygenase; Umbilical Cord; Ventral Tegmental Area | 2010 |
Dose-dependent loss of motor function after unilateral medial forebrain bundle rotenone lesion in rats: a cautionary note.
Topics: Analysis of Variance; Animals; Apomorphine; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Exploratory Behavior; Female; Functional Laterality; Insecticides; Medial Forebrain Bundle; Movement; Movement Disorders; Neurons; Psychomotor Performance; Rats; Rats, Long-Evans; Rotenone; Stereotyped Behavior; Tyrosine 3-Monooxygenase | 2011 |
Amelioration of rotenone-induced dopaminergic cell death in the striatum by oxytocin treatment.
Topics: Animals; Apomorphine; Behavior, Animal; Body Weight; Cell Death; Dopaminergic Neurons; Male; Neostriatum; Oxytocin; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotenone | 2012 |
Sodium salicylate protects against rotenone-induced parkinsonism in rats.
Topics: Amphetamine; Animals; Apomorphine; Corpus Striatum; Cyclooxygenase Inhibitors; Dopamine; Dose-Response Relationship, Drug; Electron Transport Complex I; Glutathione; Hydroxyl Radical; Male; Neurons; Oxidative Stress; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Rotenone; Sodium Salicylate; Substantia Nigra; Superoxide Dismutase; Uncoupling Agents | 2013 |
Environment-contact administration of rotenone: A new rodent model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Apomorphine; Body Weight; Brain; Disease Progression; Dopamine; Dopamine Agonists; Enteric Nervous System; Environmental Exposure; Housing, Animal; Male; Mice, Inbred C57BL; Motor Activity; Muscle, Skeletal; Neurons; Olfactory Perception; Parkinsonian Disorders; Rotenone; Tyrosine 3-Monooxygenase | 2015 |
Protective effects of Forsythia suspense extract with antioxidant and anti-inflammatory properties in a model of rotenone induced neurotoxicity.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apomorphine; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Forsythia; Fruit; Inflammation Mediators; Male; MAP Kinase Signaling System; Motor Activity; Neuroprotective Agents; PC12 Cells; Plant Extracts; Rats; Rotarod Performance Test; Rotenone | 2016 |
Effects of agomelatine in rotenone-induced Parkinson's disease in rats.
Topics: Acetamides; Animals; Apomorphine; Apoptosis; Brain; Cell Count; Corpus Striatum; Hypokinesia; Male; Neurons; Oxidation-Reduction; Parkinsonian Disorders; Proteins; Rats; Rotarod Performance Test; Rotation; Rotenone | 2019 |
Lacosamide exhibits neuroprotective effects in a rat model of Parkinson's disease.
Topics: Animals; Apomorphine; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Lacosamide; Male; Malondialdehyde; Mice; Neuroprotective Agents; Parkinson Disease; Rats; Rats, Sprague-Dawley; Rotenone; Substantia Nigra; Tumor Necrosis Factor-alpha | 2023 |